Changes in the intraocular cytokine levels after intravitreal bevacizumab in uveitic macular edema.
To evaluate the changes in intraocular cytokine after intravitreal bevacizumab (IVB) for uveitic cystoid macular edema (CME). The authors evaluated 9 eyes of 8 patients who underwent IVB for uveitic CME. The aqueous humor-levels of vascular endothelial growth factor (VEGF), interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β(2)were measured using suspension array technology at baseline and 1 month after IVB. The VEGF level was decreased to insignificant level (p = .008). TGF-β(2) and TNF-α levels increased significantly (p = .008 and .021, respectively). IL-6 and IL-8 showed no significant change (p = .051 and.110, respectively). IVB resulted in a significant decrease of VEGF levels, which was associated with anatomical improvement of CME at 1 month. Compensatory elevations of proinflammatory cytokines (IL-6 and IL-8) after selective VEGF inhibition were not observed. Marked elevation of TGF-β(2) after IVB seems to play an immunosuppressive role.